OneMedNet announces data supported FDA 510k clearance of Scaida BrainCT-ICH

OneMedNet (ONMD) announced that its clinical data supported mlHealth 360 in obtaining U.S. Food and Drug Administration, FDA, 510(k) clearance for Scaida BrainCT-ICH. Aaron Green, CEO and President of OneMedNet, stated, “We are proud to collaborate with our premier partner mlHealth 360 and to support their efforts in advancing patient care through clinically impactful AI. Seeing OneMedNet’s regulatory-grade Real-World Data-enriched with medical imaging and EMR context-contribute directly to an FDA-cleared solution reinforces the value of high-quality data in accelerating meaningful innovation. This collaboration highlights our mission to responsibly unlock healthcare data and enable partners like mlHealth 360 to deliver better outcomes at scale.”